Based on the three biomarkers, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2), breast cancers are divided into the following three major subcategories: hormone receptor+/HER2−, HER2+, and triple-negative (when none of the three biomarkers is detected). This evidence concerns the gene ESR1 and breast carcinoma.